NO984189D0 - Fremgangsmåte for behandling av bipolar forstyrrelse - Google Patents
Fremgangsmåte for behandling av bipolar forstyrrelseInfo
- Publication number
- NO984189D0 NO984189D0 NO984189A NO984189A NO984189D0 NO 984189 D0 NO984189 D0 NO 984189D0 NO 984189 A NO984189 A NO 984189A NO 984189 A NO984189 A NO 984189A NO 984189 D0 NO984189 D0 NO 984189D0
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- treatment
- bipolar disorder
- bipolar
- disorder
- Prior art date
Links
- 208000020925 Bipolar disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1315996P | 1996-03-11 | 1996-03-11 | |
| PCT/US1996/019575 WO1997033577A1 (en) | 1996-03-11 | 1996-12-04 | Method for treating bipolar disorder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO984189L NO984189L (no) | 1998-09-11 |
| NO984189D0 true NO984189D0 (no) | 1998-09-11 |
Family
ID=21758606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO984189A NO984189D0 (no) | 1996-03-11 | 1998-09-11 | Fremgangsmåte for behandling av bipolar forstyrrelse |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0889725A4 (cs) |
| JP (1) | JP2000506859A (cs) |
| KR (1) | KR19990087713A (cs) |
| CN (1) | CN1213966A (cs) |
| AU (1) | AU734011B2 (cs) |
| BR (1) | BR9612548A (cs) |
| CZ (1) | CZ290298A3 (cs) |
| EA (1) | EA000758B1 (cs) |
| HU (1) | HUP9903679A3 (cs) |
| IL (1) | IL126162A0 (cs) |
| NO (1) | NO984189D0 (cs) |
| NZ (1) | NZ326031A (cs) |
| PL (1) | PL328925A1 (cs) |
| TR (1) | TR199801797T2 (cs) |
| WO (1) | WO1997033577A1 (cs) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0101901A3 (en) * | 1998-05-22 | 2002-06-28 | Lilly Co Eli | Pharmaceutical composition for combined therapeutic treatment of refractory depression and combined treating process |
| US6960577B2 (en) | 1998-05-22 | 2005-11-01 | Eli Lilly And Company | Combination therapy for treatment of refractory depression |
| BR9911068A (pt) * | 1998-05-29 | 2001-02-06 | Lilly Co Eli | Terapia combinada para tratamento de distúrbios bipolares |
| EP1133299A1 (en) | 1998-11-23 | 2001-09-19 | Sepracor Inc. | 2-hydroxymethylolanzapine compositions and methods |
| CA2351718A1 (en) | 1998-11-23 | 2000-06-02 | Sepracor Inc. | Desmethylolanzapine compositions and methods |
| JP2002530340A (ja) * | 1998-11-23 | 2002-09-17 | セプラコール， インク． | オランザピン−ｎ−オキサイドを含む医薬組成物 |
| US20140206667A1 (en) | 2012-11-14 | 2014-07-24 | Michela Gallagher | Methods and compositions for treating schizophrenia |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5229382A (en) * | 1990-04-25 | 1993-07-20 | Lilly Industries Limited | 2-methyl-thieno-benzodiazepine |
| US5457101A (en) * | 1994-06-03 | 1995-10-10 | Eli Lilly And Company | Thieno[1,5]benzoidiazepine use |
-
1996
- 1996-12-04 HU HU9903679A patent/HUP9903679A3/hu unknown
- 1996-12-04 KR KR1019980707180A patent/KR19990087713A/ko not_active Withdrawn
- 1996-12-04 NZ NZ326031A patent/NZ326031A/en unknown
- 1996-12-04 WO PCT/US1996/019575 patent/WO1997033577A1/en not_active Ceased
- 1996-12-04 AU AU13307/97A patent/AU734011B2/en not_active Ceased
- 1996-12-04 IL IL12616296A patent/IL126162A0/xx unknown
- 1996-12-04 JP JP9532570A patent/JP2000506859A/ja active Pending
- 1996-12-04 TR TR1998/01797T patent/TR199801797T2/xx unknown
- 1996-12-04 PL PL96328925A patent/PL328925A1/xx unknown
- 1996-12-04 CN CN96180183A patent/CN1213966A/zh active Pending
- 1996-12-04 CZ CZ982902A patent/CZ290298A3/cs unknown
- 1996-12-04 EA EA199800819A patent/EA000758B1/ru not_active IP Right Cessation
- 1996-12-04 BR BR9612548A patent/BR9612548A/pt not_active Application Discontinuation
- 1996-12-04 EP EP96944772A patent/EP0889725A4/en not_active Withdrawn
-
1998
- 1998-09-11 NO NO984189A patent/NO984189D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ290298A3 (cs) | 1999-10-13 |
| PL328925A1 (en) | 1999-03-01 |
| TR199801797T2 (xx) | 1998-12-21 |
| EA000758B1 (ru) | 2000-04-24 |
| HUP9903679A2 (hu) | 2000-04-28 |
| NO984189L (no) | 1998-09-11 |
| EA199800819A1 (ru) | 1999-02-25 |
| JP2000506859A (ja) | 2000-06-06 |
| AU734011B2 (en) | 2001-05-31 |
| AU1330797A (en) | 1997-10-01 |
| HUP9903679A3 (en) | 2001-10-29 |
| EP0889725A1 (en) | 1999-01-13 |
| IL126162A0 (en) | 1999-05-09 |
| WO1997033577A1 (en) | 1997-09-18 |
| NZ326031A (en) | 2001-05-25 |
| EP0889725A4 (en) | 2000-01-19 |
| KR19990087713A (ko) | 1999-12-27 |
| BR9612548A (pt) | 1999-07-20 |
| CN1213966A (zh) | 1999-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO984431D0 (no) | FremgangsmÕte for behandling av smerte | |
| NO991955L (no) | FremgangsmÕte for behandling av hydrokarboner | |
| NO991381L (no) | Kombinasjonsterapi for behandling av psykoser | |
| NO20005864D0 (no) | Quinasoler til behandling av hjernesvulst | |
| NO20005884D0 (no) | Kombinasjonsterapi for behandling av bipolare forstyrrelser | |
| NO983284D0 (no) | Antikoagolante midler egnet i behandling av trombose | |
| FI971568A0 (fi) | Menetelmä resistenttien kasvainten hoitamiseksi | |
| NO983266D0 (no) | Distribuert Behandling | |
| NO974554L (no) | FremgangsmÕte for behandling av en underjordisk formasjon | |
| NO976063D0 (no) | Fremgangsmåte for behandling av diabetes | |
| NO990722D0 (no) | FremgangsmÕte for behandling av hjertesvikt | |
| FI964572A0 (fi) | Prosessi propeenin homo- tai kopolymeerien valmistProsessi propeenin homo- tai kopolymeerien valmistamiseksi amiseksi | |
| ATE347372T1 (de) | Vakzine zur behandlung von mycosen | |
| NO984432D0 (no) | FremgangsmÕte for behandling av migrenesmerte | |
| NO983263L (no) | Distribuert behandling | |
| NO984446D0 (no) | FremgangsmÕte for behandling av smerte | |
| IS4789A (is) | Meðferðarefnasambönd | |
| ATE226071T1 (de) | Antikonvulsive derivate zur behandlung von neuropathischem schmerz | |
| NO991734D0 (no) | Pyrazolinoner for behandling av potensforstyrrelser | |
| NO991460D0 (no) | Anvendelse av 1-hydroksy-2-pyridoner til behandling av seborÚisk dermatitt | |
| NO984189D0 (no) | Fremgangsmåte for behandling av bipolar forstyrrelse | |
| DE69834937D1 (de) | Antibiotika zur behandlung von magengeschwuren | |
| NO973366D0 (no) | Fremgangsmåte for behandling av multippel sklerose | |
| NO20003481D0 (no) | FremgangsmÕte for behandling av COPD | |
| NO982562D0 (no) | Sammensetning for behandling av smerte |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |